Digital Therapeutics Market by Application (Prevention (Obesity, Prediabetes), Sales Channel (B2C (Caregiver, Patient), B2B (Payer, Employer, Provider, Pharma)), Care (Diabetes, CRD, CVD, CNS, Smoking Cessation, Musculoskeletal)), – 2019 to 2024

$3,850.00$5,850.00

AVAIL 20% DISCOUNT ON PURCHASE OF ANY REPORT
Published on: May 28, 2019
Clear
SKU: GMS423 Category:

The global market for digital therapeutics is expected to hit USD 613.25 million by 2024, growing from 2019 to 2024 at a CAGR of 25.52%. The factors that drive the market growth include increasing incidence of chronic diseases, increasing focus on preventive health care, technological advances, significant increase in investment in venture capital, and the benefits of digital therapy.

Digital Therapeutics Market by Application (Prevention (Obesity, Prediabetes), Sales Channel (B2C (Caregiver, Patient), B2B (Payer, Employer, Provider, Pharma)), Care (Diabetes, CRD, CVD, CNS, Smoking Cessation, Musculoskeletal)), - 2019 to 2024 1

Digital Therapeutics Market by Application (Prevention (Obesity, Prediabetes), Sales Channel (B2C (Caregiver, Patient), B2B (Payer, Employer, Provider, Pharma)), Care (Diabetes, CRD, CVD, CNS, Smoking Cessation, Musculoskeletal)), - 2019 to 2024 2

Digital Therapeutics Market by Application (Prevention (Obesity, Prediabetes), Sales Channel (B2C (Caregiver, Patient), B2B (Payer, Employer, Provider, Pharma)), Care (Diabetes, CRD, CVD, CNS, Smoking Cessation, Musculoskeletal)), - 2019 to 2024 3

Digital Therapeutics Market by Application (Prevention (Obesity, Prediabetes), Sales Channel (B2C (Caregiver, Patient), B2B (Payer, Employer, Provider, Pharma)), Care (Diabetes, CRD, CVD, CNS, Smoking Cessation, Musculoskeletal)), - 2019 to 2024 4

Digital Therapeutics Market by Application (Prevention (Obesity, Prediabetes), Sales Channel (B2C (Caregiver, Patient), B2B (Payer, Employer, Provider, Pharma)), Care (Diabetes, CRD, CVD, CNS, Smoking Cessation, Musculoskeletal)), - 2019 to 2024 5

Digital Therapeutics Market by Application (Prevention (Obesity, Prediabetes), Sales Channel (B2C (Caregiver, Patient), B2B (Payer, Employer, Provider, Pharma)), Care (Diabetes, CRD, CVD, CNS, Smoking Cessation, Musculoskeletal)), - 2019 to 2024 6

Digital Therapeutics Market by Application (Prevention (Obesity, Prediabetes), Sales Channel (B2C (Caregiver, Patient), B2B (Payer, Employer, Provider, Pharma)), Care (Diabetes, CRD, CVD, CNS, Smoking Cessation, Musculoskeletal)), - 2019 to 2024 7

Digital Therapeutics Market by Application (Prevention (Obesity, Prediabetes), Sales Channel (B2C (Caregiver, Patient), B2B (Payer, Employer, Provider, Pharma)), Care (Diabetes, CRD, CVD, CNS, Smoking Cessation, Musculoskeletal)), - 2019 to 2024 8

1 Global Digital Therapeutics Market 
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global Digital Therapeutics Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global Digital Therapeutics Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global Digital Therapeutics Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global Digital Therapeutics Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global Digital Therapeutics Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global Digital Therapeutics Market – By Application (Market Size – & million/billion)
8.1 Preventive
8.2 Treatment/Care

9 Global Digital Therapeutics Market – By Sales Channel
9.1 B2C
9.2 B2B

10 Global Digital Therapeutics Market – By Geography (Market Size – & million/billion)
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 U.K
10.3.2 Germany
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia-Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 South Korea
10.4.5 Rest of APAC
10.5 Rest of the World
10.5.1 South America
10.5.2 Middle East
10.5.3 Africa

11 Global Digital Therapeutics Market – Entropy
11.1 New product launches
11.2 M&A’s, collaborations, JVs and partnerships

12 Global Digital Therapeutics Market Company Profile (Key Players)
12.1 Market Share, Company Revenue, Products, M&A, Developments
12.2 Proteus Digital Health, Inc.
12.3 Omada Health, Inc.
12.4 Welldoc, Inc.
12.5 2morrow Inc.
12.6 Canary Health Inc.
12.7 Mango Health Inc.
12.8 Livongo Health
12.9 Ginger.Io, Inc.
12.10 Propeller Health
12.11 Noom Inc.
12.12 Company 11 & more

13 Global Digital Therapeutics Market – Appendix
13.1 Sources
13.2 Abbreviations